GE HealthCare Technologies Inc
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
GEHC$83.65-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Condensed Consolidated Statements of Cash Flows (Unaudited) | ||
|---|---|---|
| For the three months ended March 31 | ||
| (In millions) | 2025 | 2024 |
| Net income | $588 | $388 |
| Adjustments to reconcile Net income to Cash from (used for) operating activities | ||
| Depreciation of property, plant, and equipment | 66 | 68 |
| Amortization of intangible assets | 70 | 80 |
| Gain on remeasurement of Nihon Medi-Physics equity method investment | (97) | — |
| Net periodic postretirement benefit plan (income) expense | (70) | (90) |
| Postretirement plan contributions | (98) | (87) |
| Share-based compensation | 22 | 34 |
| Provision for income taxes | 104 | 124 |
| Cash paid during the year for income taxes | (91) | (86) |
| Changes in operating assets and liabilities, excluding the effects of acquisitions: | ||
| Receivables | 81 | 165 |
| Inventories | (154) | (59) |
| Contract and other deferred assets | 52 | 32 |
| Accounts payable | 146 | 31 |
| Contract liabilities | (68) | (18) |
| Current compensation and benefits | (200) | (34) |
| All other operating activities – net | (101) | (129) |
| Cash from (used for) operating activities | 250 | 419 |
| Cash flows – investing activities | ||
| Additions to property, plant and equipment and internal-use software | (152) | (145) |
| Purchases of businesses, net of cash acquired | (269) | — |
| Purchases of investments | (20) | (19) |
| All other investing activities – net | 34 | (24) |
| Cash from (used for) investing activities | (407) | (188) |
| Cash flows – financing activities | ||
| Net increase (decrease) in borrowings (maturities of 90 days or less) | 1 | 1 |
| Newly issued debt, net of debt issuance costs (maturities longer than 90 days) | — | 1 |
| Repayments and other reductions (maturities longer than 90 days) | (257) | (153) |
| Dividends paid to stockholders | (16) | (14) |
| Proceeds from stock issued under employee benefit plans | 20 | 16 |
| Taxes paid related to net share settlement of equity awards | (28) | (11) |
| All other financing activities – net | (6) | 7 |
| Cash from (used for) financing activities | (286) | (153) |
| Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | 27 | (19) |
| Increase (decrease) in cash, cash equivalents, and restricted cash | (416) | 59 |
| Cash, cash equivalents, and restricted cash at beginning of year | 2,893 | 2,506 |
| Cash, cash equivalents, and restricted cash at end of period | $2,476 | $2,565 |
| Supplemental disclosure of cash flows information | ||
| Cash paid during the year for interest | $(78) | $(55) |
| Non-cash investing activities | ||
| Acquired but unpaid property, plant, and equipment | $86 | $53 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.